X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS LUPIN LTD DR. DATSONS LABS/
LUPIN LTD
 
P/E (TTM) x -10.9 161.5 - View Chart
P/BV x 0.2 3.0 5.4% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 DR. DATSONS LABS   LUPIN LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
LUPIN LTD
Mar-17
DR. DATSONS LABS/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs1261,750 7.2%   
Low Rs311,384 2.2%   
Sales per share (Unadj.) Rs133.0387.4 34.3%  
Earnings per share (Unadj.) Rs0.256.6 0.3%  
Cash flow per share (Unadj.) Rs6.676.8 8.6%  
Dividends per share (Unadj.) Rs07.50 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs128.8298.9 43.1%  
Shares outstanding (eoy) m31.66451.58 7.0%   
Bonus/Rights/Conversions FCCBESOPS-  
Price / Sales ratio x0.64.0 14.5%   
Avg P/E ratio x516.127.7 1,865.6%  
P/CF ratio (eoy) x11.820.4 58.1%  
Price / Book Value ratio x0.65.2 11.6%  
Dividend payout %013.2 0.0%   
Avg Mkt Cap Rs m2,477707,513 0.4%   
No. of employees `000NA16.8 0.0%   
Total wages/salary Rs m5628,495 0.2%   
Avg. sales/employee Rs ThNM10,418.3-  
Avg. wages/employee Rs ThNM1,697.0-  
Avg. net profit/employee Rs ThNM1,523.0-  
INCOME DATA
Net Sales Rs m4,211174,943 2.4%  
Other income Rs m791,065 7.4%   
Total revenues Rs m4,289176,008 2.4%   
Gross profit Rs m56944,931 1.3%  
Depreciation Rs m2049,122 2.2%   
Interest Rs m4301,525 28.2%   
Profit before tax Rs m1335,349 0.0%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m-283 -2.2%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m69,785 0.1%   
Profit after tax Rs m525,575 0.0%  
Gross profit margin %13.525.7 52.6%  
Effective tax rate %48.027.7 173.5%   
Net profit margin %0.114.6 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,852119,542 5.7%   
Current liabilities Rs m6,71161,206 11.0%   
Net working cap to sales %3.333.3 10.0%  
Current ratio x1.02.0 52.3%  
Inventory Days Days16176 211.6%  
Debtors Days Days31890 354.4%  
Net fixed assets Rs m3,673131,660 2.8%   
Share capital Rs m317903 35.1%   
"Free" reserves Rs m3,761134,073 2.8%   
Net worth Rs m4,078134,976 3.0%   
Long term debt Rs m1,67156,478 3.0%   
Total assets Rs m12,633266,073 4.7%  
Interest coverage x1.024.2 4.3%   
Debt to equity ratio x0.40.4 97.9%  
Sales to assets ratio x0.30.7 50.7%   
Return on assets %3.410.2 33.8%  
Return on equity %0.118.9 0.6%  
Return on capital %7.719.3 39.8%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96481,885 1.2%   
Fx outflow Rs m60721,506 2.8%   
Net fx Rs m35760,378 0.6%   
CASH FLOW
From Operations Rs m1,34541,148 3.3%  
From Investments Rs m-2,256-25,287 8.9%  
From Financial Activity Rs m-1,2004,332 -27.7%  
Net Cashflow Rs m-2,11120,193 -10.5%  

Share Holding

Indian Promoters % 4.5 46.6 9.7%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 1.4 31.9 4.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 10.1 931.7%  
Shareholders   20,807 98,259 21.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   CIPLA  PFIZER  ALKEM LABORATORIES  SHASUN PHARMA  SANOFI INDIA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS